With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, HCV Action organised a webinar to discuss how services have been affected in different areas across the country and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.
Hepatitis C Annual Epidemiological Report for 2017
Download
The European Centre for Disease Prevention and Control has published a new report on the prevalence of hepatitis C in Europe. The report indicates a 10% decrease in newly reported hepatitis C cases from 2016 to 2017, but also warns of the under-reporting of diagnosed cases and the variation of national testing practices impacting the reliability of this statistic. Headline figures show that 5.6 million Europeans live with chronic hepatitis C, with more than 31,000 recorded cases in 2017. The highest rate of newly diagnosed cases was among men between 25 and 44 years old, and injecting drug use was still the predominant route of transmission though the report highlights increasing concerns over incidence of hepatitis C among men who have sex with men. The report recommends targeted local prevention methods as outlined by the WHO action plan.
